EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms

BACKGROUND: Exostosin like glycosyltransferase 3 (EXTL3) had been reported to be associated with immune deficiency and play prognostic roles in various cancers. However, little is known about the associations between EXTL3 and prostate cancer (PCa). Hence, this article was designed to clarify their...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Pingan, Chen, Shenglan, Chang, Xiumei, Zhu, Jiaxi, Tang, Qingsheng, Ma, Limin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275153/
https://www.ncbi.nlm.nih.gov/pubmed/35818069
http://dx.doi.org/10.1186/s40001-022-00740-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275153/
https://www.ncbi.nlm.nih.gov/pubmed/35818069
http://dx.doi.org/10.1186/s40001-022-00740-w

Ejemplares similares